Achieve Life Sciences (ACHV) EBIT Margin (2010 - 2015)
Achieve Life Sciences' (ACHV) quarterly EBIT Margin came in at 20.35% in Q4 2015, down 105.6% on a QoQ basis from 363.15% in Q4 2012.
Analysis
Achieve Life Sciences (ACHV) EBIT Margin (2010 - 2015) Analysis & Trends
Achieve Life Sciences (ACHV) has 4 years of EBIT Margin data on file, last reported at 20.35% in Q4 2015.
- Quarterly EBIT Margin changed N/A year-over-year to 20.35% in Q4 2015, while the trailing twelve-month figure through Dec 2015 was 267.2% (changed N/A YoY) and the FY2015 annual result came in at 2.16%, changed N/A from the prior year.
- EBIT Margin slipped to 20.35% in Q4 2015, from 363.15% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 363.15% in Q4 2012 to a low of 7012.62% in Q4 2011.
- A 3-year average of 726.59% and a median of 126.18% in 2012 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2011 — EBIT Margin plunged 689266 bps — and 2012, when it jumped 737577 bps.
- Tracing ACHV's EBIT Margin over 3 years: stood at 7012.62% in 2011, then surged by 105 bps to 363.15% in 2012, then sank by 106 bps to 20.35% in 2015.
- The last three EBIT Margin figures came in at 20.35% (Q4 2015), 363.15% (Q4 2012), and 126.18% (Q3 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | -20.50% |
| Dec 31, 2012 | -389.50% |
| Sep 30, 2012 | 126.18% |
| Jun 30, 2012 | 244.71% |
| Mar 31, 2012 | -418.16% |
| Dec 31, 2011 | -1,600.08% |
| Sep 30, 2011 | 348.98% |
| Jun 30, 2011 | 264.60% |
| Mar 31, 2011 | -435.78% |
| Dec 31, 2010 | -119.97% |
| Sep 30, 2010 | -142.33% |
| Jun 30, 2010 | -167.72% |